Newsroom press releases

11/11/15 - 1:00

The Board of Directors approves the results for Q3'15 (778.06 KB)

Financial Data

Download

09/09/15 - 2:00

DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)

Products Molecular

Download

30/07/15 - 2:00

H1'15 Results (777.06 KB)

Financial Data

Download

20/07/15 - 2:00

DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)

Acquisition / Partnership

Download

28/05/15 - 2:00

DiaSorin launches the test for Campylobacter (241.86 KB)

Products Immunodiagnostic

Download

12/05/15 - 2:00

The Board of Directors approves the results for Q1'15 (553.96 KB)

Financial Data

Download

12/05/15 - 2:00

DiaSorin presents the 2015-2017 industrial plan (305.81 KB)

Other

Download

29/04/15 - 2:00

DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)

Products Immunodiagnostic

Download

23/04/15 - 2:00

DiaSorin supports the Pinocchio Project (251.16 KB)

Download

22/04/15 - 2:00

The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day (141.85 KB)

Financial Data

Download

22/04/15 - 2:00

Shareholders' meeting approves FY Results 2014 (105.93 KB)

Financial Data

Download

14/04/15 - 2:00

DiaSorin launches the tests for Bordetella pertussis (187.11 KB)

Products Immunodiagnostic

Download

10/04/15 - 2:00

Investor Day-save the date (107.93 KB)

Financial Data

Download

24/03/15 - 1:00

DiaSorin in aid of Haiti's children in partnership with the Francesca Rava Foundation (504.27 KB)

Download

03/03/15 - 1:00

The Board of Directors approves the results for FY'14 (783.03 KB)

Financial Data

Download

24/02/15 - 1:00

DiaSorin supports Emergency in Sudan (612.64 KB)

Download

13/02/15 - 1:00

DiaSorin teams with FISIP for Progetto talenti (612.64 KB)

Download

14/01/15 - 1:00

DiaSorin launches the test for Calprotectin (259.67 KB)

Products Immunodiagnostic

Download

08/11/13 - 1:00

The Board of Directors approves the Q3'13 Results (766.57 KB)

Financial Data

Download

29/10/13 - 1:00

DiaSorin signes a 5-year agreement with Roche (432.42 KB)

Acquisition / Partnership

Download

25/10/13 - 2:00

DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)

Products Immunodiagnostic

Download

10/10/13 - 2:00

DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)

Products Immunodiagnostic

Download

24/09/13 - 2:00

DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)

Products Immunodiagnostic

Download

01/08/13 - 2:00

The Board of Directors approves the results for the H1 '13 (386.67 KB)

Financial Data

Download

24/07/13 - 2:00

DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)

Products

Download

11/07/13 - 2:00

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)

Products Immunodiagnostic

Download

28/06/13 - 2:00

DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)

Products Immunodiagnostic

Download

20/06/13 - 2:00

DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)

Products Immunodiagnostic

Download

10/05/13 - 2:00

The Board of Directors approves the results for Q1'13 (763.61 KB)

Financial Data

Download

02/05/13 - 2:00

Compensation Commitee-Errata corrige (179.38 KB)

Financial Data

Download

22/04/13 - 2:00

Shareholders' meeting approves FY Results 2012 (57.22 KB)

Financial Data

Download

17/04/13 - 2:00

FDA approves the Aldosterone assay (439.58 KB)

Products Immunodiagnostic

Download

02/04/13 - 2:00

DiaSorin signs an agreement with Seegene (243.64 KB)

Acquisition / Partnership

Download

08/03/13 - 1:00

The BoD approves FY 2012 results (477.24 KB)

Financial Data

Download

07/03/13 - 1:00

Notification of changes in share capital (46.86 KB)

Financial Data

Download

07/03/13 - 1:00

Notice availability By-Laws (36.87 KB)

Financial Data

Download

07/02/13 - 1:00

Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)

Products Immunodiagnostic

Download

07/02/13 - 1:00

Notification of changes in share capital (46.89 KB)

Financial Data

Download

07/02/13 - 1:00

Notice availability By-Laws (139.13 KB)

Financial Data

Download

30/01/13 - 1:00

The Board of Directors approves the results for the FY '12 (477.24 KB)

Financial Data

Download

29/01/13 - 1:00

Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)

Products Immunodiagnostic

Download

Newsroom press releases

Select year

Newsroom press category

The Board of Directors approves the results for Q3'15 (778.06 KB)

DiaSorin launches the two fastest molecular diagnostic tests in the world to detect fulminant leukemias (229.24 KB)

H1'15 Results (777.06 KB)

DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)

DiaSorin launches the test for Campylobacter (241.86 KB)

The Board of Directors approves the results for Q1'15 (553.96 KB)

DiaSorin presents the 2015-2017 industrial plan (305.81 KB)

DiaSorin - launches the test for Brahms-Sepsis (506.96 KB)

DiaSorin supports the Pinocchio Project (251.16 KB)

The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day (141.85 KB)

Shareholders' meeting approves FY Results 2014 (105.93 KB)

DiaSorin launches the tests for Bordetella pertussis (187.11 KB)

Investor Day-save the date (107.93 KB)

DiaSorin in aid of Haiti's children in partnership with the Francesca Rava Foundation (504.27 KB)

The Board of Directors approves the results for FY'14 (783.03 KB)

DiaSorin supports Emergency in Sudan (612.64 KB)

DiaSorin teams with FISIP for Progetto talenti (612.64 KB)

DiaSorin launches the test for Calprotectin (259.67 KB)

The Board of Directors approves the Q3'13 Results (766.57 KB)

DiaSorin signes a 5-year agreement with Roche (432.42 KB)

DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)

DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)

DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)

The Board of Directors approves the results for the H1 '13 (386.67 KB)

DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)

DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)

DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)

DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)

The Board of Directors approves the results for Q1'13 (763.61 KB)

Compensation Commitee-Errata corrige (179.38 KB)

Shareholders' meeting approves FY Results 2012 (57.22 KB)

FDA approves the Aldosterone assay (439.58 KB)

DiaSorin signs an agreement with Seegene (243.64 KB)

The BoD approves FY 2012 results (477.24 KB)

Notification of changes in share capital (46.86 KB)

Notice availability By-Laws (36.87 KB)

Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)

Notification of changes in share capital (46.89 KB)

Notice availability By-Laws (139.13 KB)

The Board of Directors approves the results for the FY '12 (477.24 KB)

Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)

Price Sensitive